Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.47 |
| ▸ | CNR1 | P21554 | 10/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.43 |
| ▸ | HTR3B | O95264 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.43 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13140038 | 0.89 | KDM4E (0.40) | ALDH1A1HTTL3MBTL1HTR3EHTR3B | |
| SCHEMBL9816222 | 0.86 | CNR2 (0.53) | CNR2CNR1SLC6A3ALDH1A1HTT | |
| SCHEMBL7188117 | 0.73 | NR4A2 (0.48) | ALDH1A1HTTL3MBTL1 | |
| SCHEMBL7193177 | 0.71 | TSHR (0.39) | CNR2CNR1ALDH1A1HTTL3MBTL1 | |
| SCHEMBL9657072 | 0.71 | CNR2 (0.52) | CNR2CNR1SLC6A3 | |
| SCHEMBL9657145 | 0.70 | PGR (0.54) | CNR2CNR1SLC6A3ALDH1A1L3MBTL1 | |
| SCHEMBL14541305 | 0.69 | CNR2 (0.49) | CNR2CNR1SLC6A3ALDH1A1HTT | |
| SCHEMBL9658044 | 0.66 | RORA (0.49) | CNR2CNR1SLC6A3ALDH1A1L3MBTL1 | |
| SCHEMBL7435807 | 0.66 | HTR3E (0.64) | ALDH1A1L3MBTL1HTR3EHTR3BHTR3A | |
| SCHEMBL3220484 | 0.66 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7828858-B2 | Mixture of sulfide dyes | CIBA CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-7789916-B2 | Triarylmethane dyes | CIBA CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090151091-A1 | Triarylmethane Dyes | CIBA CORP. | 2009-06-18 | — | — | US | disclosed |
| US-20090100610-A1 | Mixture of Sulfide Dyes | CIBA CORPORATION | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090100610-A1 | Mixture of Sulfide Dyes | KRT18, TST, ARSA | CNR2 4297/4885CNR1 4394/4885SLC6A3 2847/4885 |
| US-20090151091-A1 | Triarylmethane Dyes | CBR3, CCNB1, CYC1 | CNR2 235/4885CNR1 171/4885SLC6A3 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.